Literature DB >> 27719663

Astrocytes as an HIV Reservoir: Mechanism of HIV Infection.

Guan-Han Li1, Lisa Henderson, Avindra Nath.   

Abstract

If we have any hope of achieving a cure for HIV infection, close attention to the cell types capable of getting infected with HIV is necessary. Of these cell types, astrocytes are the most ideal cell type for the formation of such a reservoir. These are long-lived cells with a very low turnover rate and are found in the brain and the gastrointestinal tract. Although astrocytes are evidently resistant to infection of cell-free HIV in vitro, these cells are efficiently infected via cell-tocell contact by which immature HIV virions bud off lymphocytes and have the ability to directly bind to CXCR4, triggering the process of fusion in the absence of CD4. In this review, we closely examine the evidence for HIV infection of astrocytes in the brain and the mechanisms for viral entry and regulation in this cell type, and discuss an approach for controlling this viral reservoir.

Entities:  

Mesh:

Year:  2016        PMID: 27719663     DOI: 10.2174/1570162x14666161006121455

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  40 in total

Review 1.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

2.  Early Sites of Virus Replication After Oral SIVmac251 Infection of Infant Macaques: Implications for Pathogenesis.

Authors:  Angela M Amedee; Bonnie Phillips; Kara Jensen; Spencer Robichaux; Nedra Lacour; Mark Burke; Michael Piatak; Jeffrey D Lifson; Pamela A Kozlowski; Koen K A Van Rompay; Kristina De Paris
Journal:  AIDS Res Hum Retroviruses       Date:  2018-01-17       Impact factor: 2.205

Review 3.  The role of Pannexin-1 channels and extracellular ATP in the pathogenesis of the human immunodeficiency virus.

Authors:  Daniela D'Amico; Silvana Valdebenito; Eliseo A Eugenin
Journal:  Purinergic Signal       Date:  2021-09-20       Impact factor: 3.765

Review 4.  Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.

Authors:  Rowan Saloner; Jerel Adam Fields; Maria Cecilia Garibaldi Marcondes; Jennifer E Iudicello; Sofie von Känel; Mariana Cherner; Scott L Letendre; Marcus Kaul; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-15       Impact factor: 4.147

Review 5.  Role of Connexin and Pannexin containing channels in HIV infection and NeuroAIDS.

Authors:  Shaily Malik; Eliseo A Eugenin
Journal:  Neurosci Lett       Date:  2017-09-05       Impact factor: 3.046

6.  Viral Vector-Mediated Gene Transfer of Glutamic Acid Decarboxylase for Chronic Pain Treatment: A Literature Review.

Authors:  Megumi Kanao-Kanda; Hirotsugu Kanda; Shue Liu; Sabita Roy; Michal Toborek; Shuanglin Hao
Journal:  Hum Gene Ther       Date:  2020-03-24       Impact factor: 5.695

7.  Insights into the Gene Expression Profiles of Active and Restricted Red/Green-HIV+ Human Astrocytes: Implications for Shock or Lock Therapies in the Brain.

Authors:  Venkata Viswanadh Edara; Anuja Ghorpade; Kathleen Borgmann
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

Review 8.  Neuroimmune crosstalk in the pathophysiology of hypertension.

Authors:  Laura Calvillo; Mariela M Gironacci; Lia Crotti; Pier Luigi Meroni; Gianfranco Parati
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

9.  In vitro models of HIV-1 infection of the Central Nervous System.

Authors:  Celeste Faia; Karlie Plaisance-Bonstaff; Francesca Peruzzi
Journal:  Drug Discov Today Dis Models       Date:  2019-12-20

10.  Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brain.

Authors:  Pengbo Guo; Mengjie Si; Di Wu; Hui Yi Xue; Wenhui Hu; Ho Lun Wong
Journal:  J Control Release       Date:  2020-10-01       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.